PDB Short entry for 3WZU HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-OCT-14 3WZU TITLE THE STRUCTURE OF MAP2K7 IN COMPLEX WITH 5Z-7-OXOZEAENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MAP KINASE KINASE 7, UNP RESIDUES 120-418; COMPND 5 SYNONYM: MAP KINASE KINASE 7, MAPKK 7, JNK-ACTIVATING KINASE 2, COMPND 6 MAPK/ERK KINASE 7, MEK 7, STRESS-ACTIVATED PROTEIN KINASE KINASE 4, COMPND 7 SAPK KINASE 4, SAPKK-4, SAPKK4, C-JUN N-TERMINAL KINASE KINASE 2, JNK COMPND 8 KINASE 2, JNKK 2; COMPND 9 EC: 2.7.12.2; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.SOGABE,Y.HASHIMOTO,T.MATSUMOTO,T.KINOSHITA REVDAT 4 08-NOV-23 3WZU 1 REMARK REVDAT 3 24-AUG-22 3WZU 1 JRNL REMARK SEQADV REVDAT 2 22-NOV-17 3WZU 1 REMARK REVDAT 1 14-JAN-15 3WZU 0 JRNL AUTH Y.SOGABE,T.MATSUMOTO,T.HASHIMOTO,Y.KIRII,M.SAWA,T.KINOSHITA JRNL TITL 5Z-7-OXOZEAENOL COVALENTLY BINDS TO MAP2K7 AT CYS218 IN AN JRNL TITL 2 UNPRECEDENTED MANNER. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 593 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 25529738 JRNL DOI 10.1016/J.BMCL.2014.12.011 REMARK 2 REMARK 2 RESOLUTION. 3.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.0 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 82.9 REMARK 3 NUMBER OF REFLECTIONS : 6957 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.322 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 339 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.01 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.09 REMARK 3 REFLECTION IN BIN (WORKING SET) : 324 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 58.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 19 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2150 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 24 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : -0.01000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.589 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.411 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.750 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.891 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.797 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2222 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2985 ; 1.839 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 266 ; 8.656 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;39.257 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 410 ;23.451 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;14.349 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 323 ; 0.140 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1640 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 3WZU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000097000. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NUMERICAL LINK TYPE DOUBLE REMARK 200 CRYSTAL MONOCHROMATOR, LIQUID REMARK 200 NITROGEN COOLING REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7998 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 36.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 30.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 36.30 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2DYL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25W/V PEG3350, 0.2M SODIUM CITRATE, PH REMARK 280 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.60567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 179.21133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 134.40850 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 224.01417 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 44.80283 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 89.60567 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 179.21133 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 224.01417 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 134.40850 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 44.80283 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 118 REMARK 465 THR A 119 REMARK 465 GLU A 174 REMARK 465 GLU A 175 REMARK 465 ASN A 176 REMARK 465 LYS A 177 REMARK 465 ARG A 178 REMARK 465 ILE A 179 REMARK 465 LEU A 180 REMARK 465 MET A 181 REMARK 465 ASP A 182 REMARK 465 LEU A 183 REMARK 465 ASP A 184 REMARK 465 ILE A 280 REMARK 465 SER A 281 REMARK 465 GLY A 282 REMARK 465 ARG A 283 REMARK 465 LEU A 284 REMARK 465 VAL A 285 REMARK 465 ASP A 286 REMARK 465 SER A 287 REMARK 465 LYS A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 THR A 291 REMARK 465 ARG A 292 REMARK 465 SER A 293 REMARK 465 ASP A 309 REMARK 465 PRO A 310 REMARK 465 THR A 311 REMARK 465 LYS A 312 REMARK 465 SER A 419 REMARK 465 PRO A 420 REMARK 465 ARG A 421 REMARK 465 THR A 422 REMARK 465 SER A 423 REMARK 465 GLY A 424 REMARK 465 VAL A 425 REMARK 465 LEU A 426 REMARK 465 SER A 427 REMARK 465 GLN A 428 REMARK 465 PRO A 429 REMARK 465 HIS A 430 REMARK 465 LEU A 431 REMARK 465 PRO A 432 REMARK 465 PHE A 433 REMARK 465 PHE A 434 REMARK 465 ARG A 435 REMARK 465 HIS A 436 REMARK 465 HIS A 437 REMARK 465 HIS A 438 REMARK 465 HIS A 439 REMARK 465 HIS A 440 REMARK 465 HIS A 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 218 C42 1FM A 600 1.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 231 C - N - CA ANGL. DEV. = 9.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 121 139.68 75.59 REMARK 500 SER A 144 -31.65 67.80 REMARK 500 THR A 146 123.40 55.94 REMARK 500 ARG A 168 43.30 87.28 REMARK 500 LEU A 187 144.12 -15.97 REMARK 500 PHE A 202 64.66 133.17 REMARK 500 VAL A 208 84.73 34.32 REMARK 500 HIS A 257 111.55 -25.62 REMARK 500 PHE A 278 -104.81 -136.57 REMARK 500 TYR A 299 2.05 -69.51 REMARK 500 GLU A 303 13.92 -68.17 REMARK 500 ILE A 305 17.04 -157.88 REMARK 500 TYR A 315 88.88 -154.41 REMARK 500 ASP A 316 -108.47 -137.86 REMARK 500 PRO A 337 -37.45 -39.09 REMARK 500 CYS A 341 -154.89 -76.69 REMARK 500 ASP A 344 -120.23 -147.23 REMARK 500 PHE A 345 -40.85 69.94 REMARK 500 GLU A 346 8.93 -64.87 REMARK 500 VAL A 347 -60.86 -104.47 REMARK 500 THR A 349 -70.38 -65.13 REMARK 500 LYS A 350 -50.75 -27.43 REMARK 500 SER A 366 118.67 -37.99 REMARK 500 PHE A 369 -73.77 -48.10 REMARK 500 GLN A 370 -32.47 -39.50 REMARK 500 VAL A 373 -13.21 -41.86 REMARK 500 LEU A 377 35.09 -69.27 REMARK 500 ARG A 384 150.69 -48.89 REMARK 500 THR A 417 -67.39 -90.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 167 ARG A 168 45.42 REMARK 500 THR A 201 PHE A 202 -36.90 REMARK 500 ASP A 207 VAL A 208 44.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1FM A 600 DBREF 3WZU A 119 435 UNP O14733 MP2K7_HUMAN 103 419 SEQADV 3WZU MET A 118 UNP O14733 EXPRESSION TAG SEQADV 3WZU HIS A 436 UNP O14733 EXPRESSION TAG SEQADV 3WZU HIS A 437 UNP O14733 EXPRESSION TAG SEQADV 3WZU HIS A 438 UNP O14733 EXPRESSION TAG SEQADV 3WZU HIS A 439 UNP O14733 EXPRESSION TAG SEQADV 3WZU HIS A 440 UNP O14733 EXPRESSION TAG SEQADV 3WZU HIS A 441 UNP O14733 EXPRESSION TAG SEQRES 1 A 324 MET THR GLY TYR LEU THR ILE GLY GLY GLN ARG TYR GLN SEQRES 2 A 324 ALA GLU ILE ASN ASP LEU GLU ASN LEU GLY GLU MET GLY SEQRES 3 A 324 SER GLY THR CYS GLY GLN VAL TRP LYS MET ARG PHE ARG SEQRES 4 A 324 LYS THR GLY HIS VAL ILE ALA VAL LYS GLN MET ARG ARG SEQRES 5 A 324 SER GLY ASN LYS GLU GLU ASN LYS ARG ILE LEU MET ASP SEQRES 6 A 324 LEU ASP VAL VAL LEU LYS SER HIS ASP CYS PRO TYR ILE SEQRES 7 A 324 VAL GLN CYS PHE GLY THR PHE ILE THR ASN THR ASP VAL SEQRES 8 A 324 PHE ILE ALA MET GLU LEU MET GLY THR CYS ALA GLU LYS SEQRES 9 A 324 LEU LYS LYS ARG MET GLN GLY PRO ILE PRO GLU ARG ILE SEQRES 10 A 324 LEU GLY LYS MET THR VAL ALA ILE VAL LYS ALA LEU TYR SEQRES 11 A 324 TYR LEU LYS GLU LYS HIS GLY VAL ILE HIS ARG ASP VAL SEQRES 12 A 324 LYS PRO SER ASN ILE LEU LEU ASP GLU ARG GLY GLN ILE SEQRES 13 A 324 LYS LEU CYS ASP PHE GLY ILE SER GLY ARG LEU VAL ASP SEQRES 14 A 324 SER LYS ALA LYS THR ARG SER ALA GLY CYS ALA ALA TYR SEQRES 15 A 324 MET ALA PRO GLU ARG ILE ASP PRO PRO ASP PRO THR LYS SEQRES 16 A 324 PRO ASP TYR ASP ILE ARG ALA ASP VAL TRP SER LEU GLY SEQRES 17 A 324 ILE SER LEU VAL GLU LEU ALA THR GLY GLN PHE PRO TYR SEQRES 18 A 324 LYS ASN CYS LYS THR ASP PHE GLU VAL LEU THR LYS VAL SEQRES 19 A 324 LEU GLN GLU GLU PRO PRO LEU LEU PRO GLY HIS MET GLY SEQRES 20 A 324 PHE SER GLY ASP PHE GLN SER PHE VAL LYS ASP CYS LEU SEQRES 21 A 324 THR LYS ASP HIS ARG LYS ARG PRO LYS TYR ASN LYS LEU SEQRES 22 A 324 LEU GLU HIS SER PHE ILE LYS ARG TYR GLU THR LEU GLU SEQRES 23 A 324 VAL ASP VAL ALA SER TRP PHE LYS ASP VAL MET ALA LYS SEQRES 24 A 324 THR GLU SER PRO ARG THR SER GLY VAL LEU SER GLN PRO SEQRES 25 A 324 HIS LEU PRO PHE PHE ARG HIS HIS HIS HIS HIS HIS HET 1FM A 600 26 HETNAM 1FM (3S,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3- HETNAM 2 1FM METHYL-3,4,9,10-TETRAHYDRO-1H-2- HETNAM 3 1FM BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE HETSYN 1FM (5Z)-7-OXOZEAENOL FORMUL 2 1FM C19 H22 O7 FORMUL 3 HOH *24(H2 O) HELIX 1 1 ALA A 219 GLN A 227 1 9 HELIX 2 2 PRO A 231 GLY A 254 1 24 HELIX 3 3 LYS A 261 SER A 263 5 3 HELIX 4 4 ILE A 317 GLY A 334 1 18 HELIX 5 5 VAL A 347 GLU A 354 1 8 HELIX 6 6 SER A 366 LEU A 377 1 12 HELIX 7 7 LYS A 386 GLU A 392 1 7 HELIX 8 8 HIS A 393 LEU A 402 1 10 HELIX 9 9 ASP A 405 MET A 414 1 10 SHEET 1 A 2 LEU A 122 ILE A 124 0 SHEET 2 A 2 GLN A 127 TYR A 129 -1 O TYR A 129 N LEU A 122 SHEET 1 B 5 GLU A 137 GLU A 141 0 SHEET 2 B 5 VAL A 150 ARG A 154 -1 O ARG A 154 N GLU A 137 SHEET 3 B 5 VAL A 161 ARG A 168 -1 O VAL A 164 N TRP A 151 SHEET 4 B 5 ASP A 207 GLU A 213 -1 O MET A 212 N ALA A 163 SHEET 5 B 5 CYS A 198 ILE A 203 -1 N PHE A 202 O PHE A 209 SHEET 1 C 3 THR A 217 CYS A 218 0 SHEET 2 C 3 ILE A 265 LEU A 267 -1 O LEU A 267 N THR A 217 SHEET 3 C 3 ILE A 273 LEU A 275 -1 O LYS A 274 N LEU A 266 CISPEP 1 GLY A 120 TYR A 121 0 1.86 CISPEP 2 GLY A 125 GLY A 126 0 2.53 CISPEP 3 GLY A 143 SER A 144 0 18.18 CISPEP 4 THR A 146 CYS A 147 0 -1.27 CISPEP 5 ARG A 169 SER A 170 0 10.23 CISPEP 6 ASN A 172 LYS A 173 0 1.08 CISPEP 7 VAL A 186 LEU A 187 0 -6.05 CISPEP 8 LEU A 187 LYS A 188 0 15.44 CISPEP 9 ALA A 294 GLY A 295 0 0.44 CISPEP 10 PRO A 313 ASP A 314 0 -2.16 CISPEP 11 TYR A 315 ASP A 316 0 -10.88 CISPEP 12 CYS A 341 LYS A 342 0 9.70 CISPEP 13 LYS A 342 THR A 343 0 4.09 CISPEP 14 THR A 343 ASP A 344 0 -3.90 CISPEP 15 LYS A 416 THR A 417 0 6.73 SITE 1 AC1 12 MET A 142 GLY A 143 GLY A 145 THR A 146 SITE 2 AC1 12 LYS A 165 MET A 212 GLU A 213 MET A 215 SITE 3 AC1 12 CYS A 218 LYS A 221 SER A 263 LEU A 266 CRYST1 71.395 71.395 268.817 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014007 0.008087 0.000000 0.00000 SCALE2 0.000000 0.016173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003720 0.00000